---
figid: PMC12039932__IJN-20-5291-g0006
figtitle: Nanomaterial-based DDSs treat OA by targeting chondrocytes
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12039932
filename: IJN-20-5291-g0006.jpg
figlink: /pmc/articles/PMC12039932/figure/F5/
number: F5
caption: Nanomaterial-based DDSs treat OA by targeting chondrocytes. Nanomedicines
  modified with different ligands target chondrocytes through the corresponding receptors
  on chondrocytes to release functional drugs. Different nanomedicines regulate chondrocytes
  through different mechanisms. Nanomedicines down-regulate signaling pathways such
  as NF-kB, VEGF, Notch, β-catenin and Wnt3a, and up-regulate signaling pathways such
  as PI3K/AKT and AMPK. Nanomedicines also up-regulate cartilage degradation, apoptosis,
  inflammation and autophagy related genes, such as collagen, aggrecan, Bcl-2, IL-4,
  IL-10, and LC3, thereby inhibiting inflammation, apoptosis, extracellular matrix
  degradation and oxidative stress, and promoting autophagy
papertitle: 'Nanomaterial-Based Drug Delivery Systems Targeting Functional Cells for
  Osteoarthritis Treatment: Mechanisms, Challenges and Future Prospects'
reftext: Hui Kong, et al. Int J Nanomedicine. 2025;20(NA).
year: '2025'
doi: 10.2147/IJN.S518935
journal_title: International Journal of Nanomedicine
journal_nlm_ta: Int J Nanomedicine
publisher_name: Dove Press
keywords: nanomaterial-based drug delivery systems | osteoarthritis | macrophages
  | chondrocytes | synoviocytes | mesenchymal stem cells
automl_pathway: 0.9384296
figid_alias: PMC12039932__F5
figtype: Figure
redirect_from: /figures/PMC12039932__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12039932__IJN-20-5291-g0006.html
  '@type': Dataset
  description: Nanomaterial-based DDSs treat OA by targeting chondrocytes. Nanomedicines
    modified with different ligands target chondrocytes through the corresponding
    receptors on chondrocytes to release functional drugs. Different nanomedicines
    regulate chondrocytes through different mechanisms. Nanomedicines down-regulate
    signaling pathways such as NF-kB, VEGF, Notch, β-catenin and Wnt3a, and up-regulate
    signaling pathways such as PI3K/AKT and AMPK. Nanomedicines also up-regulate cartilage
    degradation, apoptosis, inflammation and autophagy related genes, such as collagen,
    aggrecan, Bcl-2, IL-4, IL-10, and LC3, thereby inhibiting inflammation, apoptosis,
    extracellular matrix degradation and oxidative stress, and promoting autophagy
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FUT3
  - MIXL1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - NFKB1
  - IL10
  - IL4
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - BCL2
  - BAX
  - WNT3A
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - DNA
  - mRNA
---
